DAMANTE, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 22.980
AS - Asia 7.614
EU - Europa 5.655
SA - Sud America 1.344
AF - Africa 159
Continente sconosciuto - Info sul continente non disponibili 27
OC - Oceania 6
Totale 37.785
Nazione #
US - Stati Uniti d'America 22.721
SG - Singapore 3.647
CN - Cina 1.602
UA - Ucraina 1.469
BR - Brasile 1.113
DE - Germania 978
HK - Hong Kong 832
IT - Italia 735
RU - Federazione Russa 590
VN - Vietnam 571
FI - Finlandia 543
SE - Svezia 326
IE - Irlanda 295
GB - Regno Unito 242
TR - Turchia 228
IN - India 209
CA - Canada 149
KR - Corea 99
FR - Francia 94
AR - Argentina 88
IR - Iran 83
BE - Belgio 68
MX - Messico 61
PL - Polonia 61
ZA - Sudafrica 59
BD - Bangladesh 51
JP - Giappone 50
EC - Ecuador 49
AT - Austria 47
NL - Olanda 40
IQ - Iraq 39
ES - Italia 36
PK - Pakistan 33
ID - Indonesia 29
CZ - Repubblica Ceca 27
AE - Emirati Arabi Uniti 23
EG - Egitto 22
RO - Romania 22
TG - Togo 22
PY - Paraguay 21
EU - Europa 19
CO - Colombia 18
CL - Cile 17
MA - Marocco 17
UZ - Uzbekistan 17
VE - Venezuela 15
SA - Arabia Saudita 14
UY - Uruguay 14
IL - Israele 12
LT - Lituania 12
AZ - Azerbaigian 11
DO - Repubblica Dominicana 11
KE - Kenya 11
RS - Serbia 9
NP - Nepal 8
PA - Panama 8
TN - Tunisia 8
BH - Bahrain 7
HU - Ungheria 7
JM - Giamaica 7
LB - Libano 7
XK - ???statistics.table.value.countryCode.XK??? 7
AU - Australia 6
BG - Bulgaria 6
CH - Svizzera 6
HR - Croazia 6
KZ - Kazakistan 6
JO - Giordania 5
PH - Filippine 5
PS - Palestinian Territory 5
PT - Portogallo 5
AL - Albania 4
DK - Danimarca 4
DZ - Algeria 4
LV - Lettonia 4
PE - Perù 4
TT - Trinidad e Tobago 4
TW - Taiwan 4
ET - Etiopia 3
GR - Grecia 3
HN - Honduras 3
LI - Liechtenstein 3
LK - Sri Lanka 3
LU - Lussemburgo 3
TH - Thailandia 3
BO - Bolivia 2
BZ - Belize 2
CR - Costa Rica 2
GA - Gabon 2
GF - Guiana Francese 2
GT - Guatemala 2
LA - Repubblica Popolare Democratica del Laos 2
MR - Mauritania 2
MY - Malesia 2
NI - Nicaragua 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
Totale 37.758
Città #
Fairfield 2.753
Woodbridge 2.054
Ashburn 2.014
Singapore 1.619
Chandler 1.409
Houston 1.400
Seattle 1.181
Ann Arbor 1.107
Wilmington 1.035
Jacksonville 965
Cambridge 956
Beijing 848
Hong Kong 829
Dearborn 626
Chicago 432
Los Angeles 431
Boardman 391
Udine 317
Dublin 292
Princeton 278
New York 251
Ho Chi Minh City 205
Munich 200
Salt Lake City 190
Izmir 186
Buffalo 167
Dallas 140
Hefei 133
San Diego 132
São Paulo 102
Hanoi 94
Seoul 94
Ogden 93
Tampa 89
Redmond 88
Redondo Beach 88
Elk Grove Village 83
Des Moines 82
Dong Ket 73
Turku 73
Norwalk 69
Phoenix 65
Brussels 63
Sterling 58
Warsaw 55
Columbus 52
Frankfurt am Main 51
Mumbai 48
Helsinki 47
San Mateo 47
Montreal 46
Tokyo 46
Augusta 45
Ottawa 45
Kunming 44
Lancaster 41
Santa Clara 41
Leawood 39
Johannesburg 38
Rio de Janeiro 38
The Dalles 37
Düsseldorf 36
Orem 36
Belo Horizonte 35
Denver 35
Nanjing 35
Trieste 35
Stockholm 34
Brooklyn 33
Grafing 33
Poplar 33
Falls Church 32
Washington 32
Ardabil 31
London 31
Miami 31
Nuremberg 30
Guangzhou 28
Atlanta 27
Chennai 27
Vienna 27
Toronto 26
Boston 24
Mexico City 24
Brasília 23
Dulles 23
Ankara 22
Lomé 22
Amsterdam 21
Da Nang 21
Lauterbourg 21
Monmouth Junction 21
Codroipo 20
Jinan 20
Pittsburgh 20
San Francisco 20
Baghdad 19
Detroit 19
Quito 19
Curitiba 18
Totale 25.559
Nome #
Critical involvement of calcium-dependent cytosolic phospholipase A2α in aortic valve interstitial cell calcification 1.082
Effects of dihydrotanshinone I on proliferation and invasiveness of paclitaxel-resistant anaplastic thyroid cancer cells 469
Fetal growth at term and placental oxidative stress in a tissue micro-array model: a histological and immunohistochemistry study 328
Functional analysis of a novel RUNX2 missense mutation found in a family with cleidocranial dysplasia 258
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients 214
A 16q deletion involving FOXF1 enhancer is associated to pulmonary capillary hemangiomatosis 206
Functional regulation of the apurinic/apyrimidinic endonuclease 1 by nucleophosmin: impact on tumor biology 202
Comparative stability analysis of the thyroid transcription factor 1 and Antennapedia homeodomains: evidence for residue 54 in controlling the structural stability of the recognition helix 199
Identification of tumorigenesis-related mRNAs associated with RNA-binding protein HuR in thyroid cancer cells 198
Evaluating the SERCA2 and VEGF mRNAs as Potential Molecular Biomarkers of the Onset and Progression in Huntington's Disease 195
BET bromodomain inhibitor JQ1 modulates microRNA expression in thyroid cancer cells 188
Down-regulation of SM22/transgelin gene expression during H9c2 cells differentiation 187
APE1/Ref-1 regulates PTEN expression mediated by EGR-1 187
Expression of differentiation markers in cultured cells from various thyroid diseases 181
TSH stimulates the activity of the c-fos promoter in FRTL5 rat thyroid cells 180
Acetylation on critical lysine residues of Apurinic/apyrimidinic endonuclease 1 (APE1) in triple negative breast cancers 180
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation 180
Different expression of TSH receptor and NIS genes in thyroid cancer: role of epigenetics. 180
IGF-I increases c-fos expression in FRTL5 rat thyroid cells by activating the c-fos promoter 179
Genomic Deletion Involving the IMMP2L Gene in Two Cases of Autism Spectrum Disorder 179
Nucleotide receptors stimulation by extracellular ATP controls Hsp90 expression through APE1/Ref-1 in thyroid cancer cells: a novel tumorigenic pathway 178
Genome-wide analysis and proteomic studies reveal APE1/Ref-1 multifunctional role in mammalian cells. 176
Expression of periostin in human breast cancer 174
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer. 174
Histone post-translational modifications induced by histone deacetylase inhibition in transcriptional control units of NIS gene 173
Histone deacetylase inhibitors control the transcription and alternative splicing of prohibitin in thyroid tumor cells 173
High periostin expression correlates with aggressiveness in papillary thyroid carcinomas 172
A Proteomic approach to identify early molecular targets of oxidative stress in human epithelial lens cells 171
A suppressor of transcriptional activity is present upstream from the rat c-Ha-ras promoter 170
Somatic amplifications and deletions in genome of papillary thyroid carcinomas 170
Temperament and character inventory in bipolar disorder versus healthy controls and modulatory effects of 3 key functional gene variants 170
Microduplication in the 2p16.1p15 chromosomal region linked to developmental delay and intellectual disability 166
Definition of the DNA-binding specificity of TTF-1 homeodomain by chromatographic selection of binding sequences 165
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells 165
Histone post-translational modifications associated to BAALC expression in leukemic cells. 164
Epigenetic bivalent marking is permissive to the synergy of HDAC and PARP inhibitors on TXNIP expression in breast cancer cells 164
In the TTF-1 homeodomain the contribution of several amino acids to DNA recognition depends on the bound sequence 163
Galectin-3 expression in non-small cell lung carcinoma 163
Nucleophosmin is overexpressed in thyroid tumors 162
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness 162
Co-operation between the PAI and RED subdomains of Pax-8 in the interaction with the thyroglobulin promoter. 161
Disruption of autoregulatory feedback by a mutation in a remote, ultraconserved PAX6 enhancer causes aniridia. 161
A molecular code dictates sequence-specific DNA recognition by homeodomains 160
BRCA2 GERMLINE MUTATIONS IN PRIMARY CANCER OF THE FALLOPIAN TUBE 160
Studies on the promoter region of the c-Ha-ras gene in FRTL5 rat thyroid cells. 159
Structural and functional properties of the N transcriptional activation domain of thyroid transcription factor-1: similarities with the acidic activation domains 159
Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer 159
FREQUENCY OF FACTOR V, PROTHROMBIN AND METHYLENETETRAHYDROFOLATE REDUCTASE GENE VARIANTS IN PREECLAMPSIA 156
Thyrotropin regulation of thyroid peroxidase messenger ribonucleic acid levels in cultured rat thyroid cells: evidence for the involvement of a nontranscriptional mechanism. 155
Activation of APE1/Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP 155
A polymorphic GGC repeat in the NPAS2 gene and its association with melanoma 155
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver 155
Molecular differences between human thyroid follicular adenoma and carcinoma revealed by analysis of a murine model of thyroid cancer. 154
Evaluation of somatic genomic imbalances in thyroid carcinomas of follicular origin by CGH-based approaches 154
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: Functional characterization 153
Analysis of the solution structure of the homeodomain of rat thyroid transcription factor 1 by 1H-NMR spectroscopy and restrained molecular mechanics 152
Nanoparticles loaded with the BET inhibitor JQ1 block the growth of triple negative breast cancer cells in vitro and in vivo 152
Blood-brain barrier dysfunction in disorders of the developing brain 150
Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia. 148
Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. 147
PAX8 expression in human bladder cancer. 147
THE ROLE OF CYP3A5 GENOTYPE AND TACROLIMUS MONITORING IN STABLE KIDNEY TRANSPLANTATIONS 147
Tracking of the origin of recurrent mutations of the BRCA1 and BRCA2 genes in the North-East of Italy and improved mutation analysis strategy 146
null 146
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells 146
A differential proteomic approach to identify proteins associated with thyroid cell transformation 146
Homology model building of the thyroid transcription factor 1 homeodomain 145
Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells 145
Redox effector factor-1 regulates the activity of thyroid transcription factor 1 by controlling the redox state of the N transcriptional activation domain 144
Mutations R67X and W303X of the protein Z-dependent protease inhibitor gene and venous thromboembolic disease: a case-control study in Italian subjects 144
APE1 and NPM1 protect cancer cells from platinum compounds cytotoxicity and their expression pattern has a prognostic value in TNBC 144
A CGH array procedure to detect PAX6 gene structural defects 144
A network of specific minor-groove contacts is a common characteristic of paired-domain-DNA interactions 143
Insulin binding and biological activities in the FRTL-5 rat thyroid cell line. 142
Immunocytochemical expression of tissue specific transcription factor-1 in lung carcinoma 142
Molecular events in the differentiation of the thyroid gland 142
Myelin protein zero Val102fs mutation manifesting with isolated spinal root hypertrophy. 142
Thyroid-specific gene expression. 141
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma 141
TSH controls ref-1 nuclear translocation in thyroid cells 141
KRAS Codons 12 and 13 Mutation Analysis: A Comparative Study between Direct Sequencing and a New Sensitive Real-Time PCR Assay 141
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours. 140
Cyclic AMP-response element modulator inhibits the promoter activity of the sodium iodide symporter gene in thyroid cancer cells. 140
CACNA1C haploinsufficiency accounts for the common features of interstitial 12p13.33 deletion carriers 140
Erratum: Functional regulation of the Apurinic/apyrimidinic endonuclease APE1 by Nucleophosmin (NPM1): Impact on tumor biology 139
Differential proteomic analysis of nuclear extracts from thyroid cell lines 139
Successful and safe long-term treatment of cerebral aspergillosis with high-dose voriconazole guided by therapeutic drug monitoring 139
Levels of histone acetylation in thyroid tumors 138
Unexpected phenotype of a typical NPM1 mutant 138
Investigation of endothelin-1 type A receptor gene polymorphism (-231 G>A) in preeclampsia susceptibility 138
Microdeletion 15q26.2qter and Microduplication 18q23 in a patient with prader-willi-like syndrome: Clinical findings 137
Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells 137
Effect of thyrotropin and cAMP on FRTL5 cell growth in a serum free medium 136
null 136
Cross-regulation between Egr-1 and APE/Ref-1 during early response to oxidative stress in the human osteoblastic HOBIT cell line: Evidence for an autoregulatory loop 135
Thyroid defects due to Pax8 gene mutations 134
Regulation of pituitary adenylate cyclase-activating polypeptide gene transcription by TTF-1, a homeodomain-containing transcription factor 134
Desensitization of the thyroid cyclic AMP response to thyroid stimulating immunoglobulin: comparison with TSH 134
CONCOMITANT BCRP OVER-EXPRESSION AND FLT3-ITD MUTATION IDENTIFY A SUBSET OF ACUTE MYELOID LEUKEMIA PATIENTS AT HIGH RISK OF RELAPSE 133
Expression and localization of the homeodomain-containing protein HEX in human thyroid tumors 133
Totale 17.271
Categoria #
all - tutte 139.703
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 139.703


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.693 0 0 0 0 0 513 198 436 498 185 611 252
2021/20222.679 169 222 80 125 102 121 171 132 40 410 744 363
2022/20232.951 322 291 49 412 281 758 6 247 389 34 98 64
2023/20241.177 149 73 42 25 182 234 16 65 141 70 43 137
2024/20255.990 115 361 255 321 284 263 445 344 692 450 937 1.523
2025/20268.313 1.362 2.339 996 1.272 1.789 555 0 0 0 0 0 0
Totale 38.369